• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

    6/3/24 5:35:57 AM ET
    $ABTS
    $AMC
    $BNAI
    $CRKN
    Computer Software: Programming Data Processing
    Technology
    Movies/Entertainment
    Consumer Discretionary
    Get the next $ABTS alert in real time by email

    Shares of GameStop Corp. (NYSE:GME) rose sharply in today's pre-market trading .

    The rally in the stock came on the back of Keith Gill, also known as "Roaring Kitty," disclosing a substantial position in GameStop on the r/Superstonk Reddit forum.

    GameStop shares jumped 69.1% to $39.12 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • MingZhu Logistics Holdings Limited (NASDAQ:YGMZ) rose 69.5% to $0.5931 in today's pre-market trading after the company reported an agreement to acquire Oxylus Global.
    • TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) shares gained 31.3% to $1.68 in pre-market trading. On May 14, TRACON Pharmaceuticals reported worse-than-expected first-quarter EPS results.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) gained 25.6% to $5.44 in pre-market trading. The resumption of the meme rally came on the back of Keith Gill, also known as "Roaring Kitty," disclosing a substantial position in GameStop on the r/Superstonk Reddit forum.
    • Earlyworks Co., Ltd (NASDAQ:ELWS) gained 25% to $2.65 in pre-market trading. Earlyworks and ZenmuTech announced a collaboration for a more secure digital society through secret splitting and blockchain.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 24% to $0.1239 in pre-market trading after dipping 12% on Friday.
    • MarineMax, Inc. (NYSE:HZO) gained 18.6% to $33.79 in pre-market trading.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares gained 17.3% to $0.6850 in pre-market trading after gaining over 3% on Friday.  
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) rose 17.2% to $1.70 in pre-market trading after gaining 5% on Friday.
    • Molecular Partners AG (NASDAQ:MOLN) shares climbed 14.4% to $4.30 in pre-market trading. Molecular Partners presented data from completed Phase 1 trial of MP0317 monotherapy in advanced solid tumors at ASCO 2024.

    Losers

    • Portage Biotech Inc (NASDAQ:PRTG) shares declined 25.2% to $0.3581 in pre-market trading after gaining over 91% on Friday.
    • iSpecimen Inc. (NASDAQ:ISPC) shares declined 23.5% to $0.3291 in pre-market trading.
    • Abits Group Inc. (NASDAQ:ABTS) shares dipped 14% to $0.58 in pre-market trading following a 4% decline on Friday.
    • XChange TEC.INC (NASDAQ:XHG) shares fell 12.5% to $0.7869 in pre-market trading after jumping around 32% on Friday.
    • Global Gas Corp (NASDAQ:HGAS) shares fell 12% to $1.10 in pre-market trading after gaining around 9% on Friday.
    • Digital Health Acquisition Corp (NASDAQ:DHAC) shares fell 11.4% to $15.03 in pre-market trading after gaining 13% on Friday.
    • Brand Engagement Network, Inc. (NASDAQ:BNAI) shares fell 11.2% to $4.83 in pre-market trading after jumping over 110% on Friday.
    • EpicQuest Education Group Internatnl Ltd (NASDAQ:EEIQ) shares fell 10.4% to $0.75 in pre-market trading after gaining over 7% on Friday.
    • UTime Ltd (NASDAQ:WTO) fell 10.4% to $0.43 in pre-market trading after gaining 10% on Friday.
    • GSK plc (NYSE:GSK) shares declined 9.2% to $40.66 in pre-market trading. GSK said it disagrees with ruling by Delaware State Court that contradicts Federal Court’s Multidistrict litigation ruling, which dismissed all cases alleging five cancer types, in Dec. 2022. The company said it will immediately seek an appeal.

    Now Read This: Investor Optimism Improves; US Stocks Record Gains For May

    Get the next $ABTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABTS
    $AMC
    $BNAI
    $CRKN

    CompanyDatePrice TargetRatingAnalyst
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    GSK plc
    $GSK
    1/27/2026Neutral
    Citigroup
    GSK plc
    $GSK
    1/6/2026Equal Weight → Underweight
    Barclays
    MarineMax Inc. (FL)
    $HZO
    12/23/2025$29.00Buy
    Loop Capital
    GSK plc
    $GSK
    11/25/2025Underperform → Neutral
    BofA Securities
    AMC Entertainment Holdings Inc.
    $AMC
    7/11/2025$4.00Neutral → Outperform
    Wedbush
    GSK plc
    $GSK
    6/3/2025Buy → Hold
    Berenberg
    AMC Entertainment Holdings Inc.
    $AMC
    5/16/2025$3.00Neutral
    B. Riley Securities
    More analyst ratings

    $ABTS
    $AMC
    $BNAI
    $CRKN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    National CineMedia, Inc. Reports Results for Fiscal Fourth Quarter and Full Year 2025

    Fourth quarter operating income increases year-over-year and fourth quarter adjusted OIBDA exceeds guidance Fourth quarter revenue growth of 8% outpaced attendance as NCM attracted greater advertiser demand National CineMedia, Inc. (NASDAQ:NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., announced today its consolidated results for the fiscal fourth quarter and year ended January 1, 2026. "NCM expanded fourth quarter revenue by 8% year-over-year, demonstrating the returns from our continued investment in our platform over the course of the year," said Tom Lesinski, Chief Execu

    2/26/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    EpicQuest Education Enters into MOU to Offer its Masters in Management Program in the South Asia Market

    TOLEDO, Ohio, Feb. 26, 2026 (GLOBE NEWSWIRE) -- EpicQuest Education Group International Limited (NASDAQ:EEIQ), ("EpicQuest Education", "EEIQ" or the "Company"), a provider of higher education for domestic and international students in the US, Canada and the UK,  today announced Davis University ("Davis") recently entered into a non-binding Memorandum of Understanding ("MOU") with M Square Business Solutions USA Inc. dba MSM Unify ("MSM") to offer Davis' Masters of Science in Management Program in an online format. The MOU was signed on February 25, 2026, and will be in effect for up to three years. "By expanding our academic presence around the globe, we are providing access to world-clas

    2/26/26 8:30:00 AM ET
    $EEIQ
    Other Consumer Services
    Real Estate

    IGY Marinas Re-Signs Management and Marketing Agreement for St. Katharine Docks Marina, London

    MarineMax, Inc. (NYSE:HZO), the world's largest recreational boat and yacht retailer, marina operator and superyacht services company, today announced that its IGY Marinas subsidiary has renewed its management and marketing agreement for St. Katharine Docks Marina in London, England. Described as a nautical enclave in the middle of one of the world's greatest cities, St. Katharine Docks Marina offers charm 200 years in its making. Situated approximately 40 nautical miles up the River Thames, it lies adjacent to the Tower of London and within walking distance of many of the city's most renowned landmarks. Opened in 1828, the docks occupy three historic interlinked basins, offering 185 bert

    2/26/26 8:15:00 AM ET
    $HZO
    Auto & Home Supply Stores
    Consumer Discretionary

    $ABTS
    $AMC
    $BNAI
    $CRKN
    SEC Filings

    View All

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/3/26 6:50:36 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/2/26 2:32:45 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/2/26 12:29:15 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTS
    $AMC
    $BNAI
    $CRKN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on Molecular Partners AG with a new price target

    H.C. Wainwright initiated coverage of Molecular Partners AG with a rating of Buy and set a new price target of $13.00

    1/27/26 8:47:34 AM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Citigroup initiated coverage on GlaxoSmithKline

    Citigroup initiated coverage of GlaxoSmithKline with a rating of Neutral

    1/27/26 8:46:26 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GlaxoSmithKline downgraded by Barclays

    Barclays downgraded GlaxoSmithKline from Equal Weight to Underweight

    1/6/26 11:51:57 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTS
    $AMC
    $BNAI
    $CRKN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ABTS
    $AMC
    $BNAI
    $CRKN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, GC AND SECRETARY Gladbach Edwin F covered exercise/tax liability with 13,427 shares and was granted 26,206 shares, increasing direct ownership by 77% to 29,324 units (SEC Form 4)

    4 - AMC ENTERTAINMENT HOLDINGS, INC. (0001411579) (Issuer)

    3/2/26 6:39:47 PM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    SVP, CHIEF ACCOUNTING OFFICER Cox Chris A was granted 78,592 shares and covered exercise/tax liability with 37,733 shares, increasing direct ownership by 64% to 104,436 units (SEC Form 4)

    4 - AMC ENTERTAINMENT HOLDINGS, INC. (0001411579) (Issuer)

    3/2/26 6:13:29 PM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    SVP, BUSINESS DEVELOPMENT Copaken Ellen was granted 73,898 shares and covered exercise/tax liability with 35,617 shares, increasing direct ownership by 84% to 83,775 units (SEC Form 4)

    4 - AMC ENTERTAINMENT HOLDINGS, INC. (0001411579) (Issuer)

    3/2/26 5:53:02 PM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ABTS
    $AMC
    $BNAI
    $CRKN
    Financials

    Live finance-specific insights

    View All

    National CineMedia, Inc. Reports Results for Fiscal Fourth Quarter and Full Year 2025

    Fourth quarter operating income increases year-over-year and fourth quarter adjusted OIBDA exceeds guidance Fourth quarter revenue growth of 8% outpaced attendance as NCM attracted greater advertiser demand National CineMedia, Inc. (NASDAQ:NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., announced today its consolidated results for the fiscal fourth quarter and year ended January 1, 2026. "NCM expanded fourth quarter revenue by 8% year-over-year, demonstrating the returns from our continued investment in our platform over the course of the year," said Tom Lesinski, Chief Execu

    2/26/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    National CineMedia, Inc. to Release Fourth Quarter and Full Year 2025 Results on February 26, 2026

    National CineMedia, Inc. (NASDAQ:NCMI), the managing member of National CineMedia, LLC ("NCM LLC"), the operator of the largest cinema advertising platform in the U.S., plans to issue its fourth quarter and full year 2025 earnings results after the market closes on Thursday, February 26, 2026. A conference call and audio webcast to discuss the results will take place at 5:00 p.m. Eastern Time. The conference call can be accessed by dialing 1-844-826-3033 or for international participants 1-412-317-5185. Participants should register at least 15 minutes prior to the commencement of the call to register, download, and install necessary audio software. Additionally, a live audio webcast will

    2/19/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026

    Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing cancersDosimetry data highlight Radio-DARPins as vector for precise delivery of potent alpha-emitting isotopes to tumorsMP0712 Phase 1/2a study open in U.S. with initial clinical data expected in 2026Molecular Partners to host conference call February 2 at 8AM ET (2PM CET), joined by renowned nuclear medicine expert Prof. Ken Herrmann, M.D. ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a clinical-stage biotech company deve

    2/2/26 1:00:00 AM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABTS
    $AMC
    $BNAI
    $CRKN
    Leadership Updates

    Live Leadership Updates

    View All

    Donerail Issues Additional Open Letter to MarineMax Shareholders

    Disappointed by Lack of Engagement with MarineMax Board Despite Highly Credible, Premium Cash Proposal and Stated Willingness to Potentially Increase Offer Urges Shareholders to Vote AGAINST CEO Brett McGill at Upcoming Annual Meeting as a Referendum on MarineMax Immediately Commencing a Comprehensive Strategic Review Commends CalSTRS for Voting AGAINST CEO Brett McGill and AGAINST All Other Company Nominees Highlights Levin Capital's Call for an Immediate Strategic Review Following Donerail's $35 Per Share Cash Proposal  LOS ANGELES, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Donerail Group ("Donerail"), one of the largest shareholders of MarineMax, Inc. (NYSE:HZO) ("MarineMax" or the "Company

    2/23/26 8:45:00 AM ET
    $HZO
    Auto & Home Supply Stores
    Consumer Discretionary

    Donerail Issues Open Letter to MarineMax Shareholders

    Calls Out Board Entrenchment, Nepotism, and Obstruction of Shareholder Engagement Urges Shareholders to Vote AGAINST CEO Brett McGill as a Director at Company's Upcoming Annual Meeting Reaffirms $35.00 per Share All-Cash Proposal as a Path to Providing Immediate Shareholder Value at Significant Premium LOS ANGELES, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The Donerail Group ("Donerail"), one of the largest shareholders of MarineMax, Inc. (NYSE:HZO) ("MarineMax" or the "Company"), beneficially owning over 4% of MarineMax's outstanding shares, today issued an open letter to the Company's shareholders further discussing its $35.00 all-cash offer to acquire the Company, its recent engagement with

    2/9/26 9:15:00 AM ET
    $HZO
    Auto & Home Supply Stores
    Consumer Discretionary

    LAIKA Partners With Fathom Entertainment for Domestic Distribution and FilmNation Entertainment for International Sales on Wildwood

    Confirms October 23, 2026 U.S. Release Date LAIKA, the studio behind Coraline and ParaNorman, announced today that it has partnered with Fathom Entertainment for U.S. theatrical distribution and FilmNation Entertainment for international sales on its upcoming stop-motion feature film Wildwood. The film will open in theaters nationwide on October 23, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120938376/en/LAIKA Names Fathom Entertainment as US Distributor and FilmNation Entertainment for International Sales for "Wildwood" coming October 23, 2026 The announcement reflects a new phase for LAIKA, as the studio expands

    1/20/26 11:15:00 AM ET
    $AMC
    $CNK
    Movies/Entertainment
    Consumer Discretionary

    $ABTS
    $AMC
    $BNAI
    $CRKN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Global Gas Corporation

    SC 13D/A - Global Gas Corp (0001817232) (Subject)

    12/10/24 7:26:35 PM ET
    $HGAS
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Abits Group Inc

    SC 13D/A - Abits Group Inc (0001864055) (Subject)

    11/21/24 6:05:10 PM ET
    $ABTS
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by TRACON Pharmaceuticals Inc.

    SC 13G/A - Tracon Pharmaceuticals, Inc. (0001394319) (Subject)

    11/14/24 8:51:58 PM ET
    $TCON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care